Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-31 Option Award |
2025-02-05 7:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | Alton Gregg H Director |
1,982 | $8.61 | 18,385 (Direct) |
View |
| 2024-03-31 Option Award |
2025-02-05 7:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | Alton Gregg H Director |
3,420 | $4.9 | 18,385 (Direct) |
View |
| 2024-06-30 Option Award |
2025-02-05 7:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | Alton Gregg H Director |
1,202 | $13.93 | 18,385 (Direct) |
View |
| 2024-09-30 Option Award |
2025-02-05 7:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | Alton Gregg H Director |
1,311 | $12.77 | 18,385 (Direct) |
View |
| 2024-06-25 Option Award |
2024-06-27 6:53 pm |
2024-06-25 2034-06-25 |
RENOVARO INC. | RENB | Alton Gregg H Director |
48,137 | $0 | 48,137 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 4:11 pm |
2024-06-12 2033-06-12 |
NOVAVAX INC | NVAX | Alton Gregg H Director |
6,670 | $0 | 36,520 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:11 pm |
2025-06-12 2034-06-12 |
NOVAVAX INC | NVAX | Alton Gregg H Director |
15,630 | $15.86 | 36,520 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:11 pm |
2025-06-12 2034-06-12 |
NOVAVAX INC | NVAX | Alton Gregg H Director |
10,420 | $0 | 36,520 (Direct) |
View |
| 2024-05-17 Option Award |
2024-05-21 6:30 pm |
N/A 2034-05-16 |
CORCEPT THERAPEUTICS INC | CORT | Alton Gregg H Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-12-27 Option Award |
2024-02-02 12:14 pm |
2024-12-27 2033-12-27 |
RENOVARO BIOSCIENCES INC. | RENB | Alton Gregg H Director |
23,810 | $0 | 23,810 (Direct) |
View |
| 2023-06-10 Exercise |
2023-06-13 4:43 pm |
N/A N/A |
NOVAVAX INC | NVAX | Alton Gregg H Director |
3,100 | $0 | 18,180 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-13 4:43 pm |
2024-06-12 2033-06-12 |
NOVAVAX INC | NVAX | Alton Gregg H Director |
14,380 | $0 | 18,180 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-23 5:00 pm |
N/A 2033-05-18 |
CORCEPT THERAPEUTICS INC | CORT | Alton Gregg H Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-12-27 Option Award |
2023-01-05 4:48 pm |
2023-12-27 2032-12-27 |
Enochian Biosciences Inc | ENOB | Alton Gregg H Director |
57,252 | $0 | 57,252 (Direct) |
View |
| 2022-06-17 Exercise |
2022-06-21 8:45 pm |
N/A N/A |
NOVAVAX INC | NVAX | Alton Gregg H Director |
700 | $0 | 700 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:06 pm |
2023-06-10 2032-06-10 |
NOVAVAX INC | NVAX | Alton Gregg H Director |
7,700 | $0 | 7,700 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 5:00 pm |
N/A 2032-05-30 |
CORCEPT THERAPEUTICS INC | CORT | Alton Gregg H Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-12-27 Option Award |
2021-12-28 9:41 pm |
2022-12-27 2031-12-27 |
Enochian Biosciences Inc | ENOB | Alton Gregg H Director |
9,458 | $0 | 9,458 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 5:15 pm |
2022-06-17 2031-06-17 |
NOVAVAX INC | NVAX | Alton Gregg H Director |
2,000 | $0 | 2,000 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 5:15 pm |
N/A 2031-05-25 |
CORCEPT THERAPEUTICS INC | CORT | Alton Gregg H Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-10-31 Option Award |
2020-11-03 6:15 pm |
2021-10-31 2030-10-31 |
NOVAVAX INC | NVAX | Alton Gregg H Director |
7,700 | $0 | 7,700 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:22 pm |
N/A 2030-05-26 |
CORCEPT THERAPEUTICS INC | CORT | Alton Gregg H Director |
30,000 | $0 | 30,000 (Direct) |
View |